Bankman-Fried, FTX Execs Received Billions in Hidden Loans, Says Ex-Alameda CEO (The Straits Times)
NEW YORK – Sam Bankman-Fried and other FTX executives received billions of dollars in secret loans from the crypto mogul’s Alameda Research, the hedge fund’s former chief told a United States judge when she pleaded guilty to her role in the exchange’s collapse. Caroline Ellison, former chief executive of Alameda Research, said she agreed with Bankman-Fried to hide from FTX’s investors, lenders and customers that the hedge fund could borrow unlimited sums from the exchange, according to a transcript of her Dec 19 plea hearing that was unsealed last Friday.
Tuesday 12/27 Insider Buying Report: CRK (Nasdaq.com)
On Thursday, Jim L. Turner bought $208,690 worth of Comstock Resources, buying 15,000 shares at a cost of $13.91 a piece. Before this latest buy, Turner made one other purchase in the past twelve months, buying $917,195 shares at a cost of $18.34 a piece. Comstock Resources is trading off about 0.6% on the day Tuesday. So far Turner is in the green, up about 6.3% on their buy based on today’s trading high of $14.79.
Ex-Durham Donor Cuts Off University Cash to Fund Fight for Free Speech (Telegraph.co.uk)
A millionaire who was formerly Durham University’s largest donor said that he is cutting off all donations to universities and instead funding the fight for free speech on campuses. Mark Hillery, a retired hedge fund manager who donated more than £7 million to his alma mater between 2015 and 2021, told The Telegraph that he will not donate to any university again until “they get their free speech house properly in order”.
$10 Million Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying (Benzinga)
Dave & Buster’s Entertainment: The Trade: Dave & Buster’s Entertainment, Inc. (PLAY) 10% owner Scott Ross acquired a total of 535,000 shares an average price of $33.51. To acquire these shares, it cost around $17.93 million. Astria Therapeutics: The Trade: Astria Therapeutics, Inc. (ATXS) Director Joseph Edelman acquired a total of 908,265 shares at an average price of $11.01. To acquire these shares, it cost around $10 million.
SEC Adopts Amendments to Rule 10b5-1 Plan Requirements and Increases Disclosure Requirements Regarding Insider Trading Policies (NatlawReview.com)
On December 14, the Securities and Exchange Commission (SEC) unanimously adopted amendments to Rule 10b5-1 and related regulations governing “10b5-1 Plans.” 10b5-1 Plans enable (1) public company insiders to sell their company’s stock or (2) issuers to repurchase their shares, each at times when they otherwise might be prevented from doing so because they possess material non-public information (MNPI).
